1219601-57-6

Basic information

• Product Name: 1-(p-tolylsulfonyl)triazole
• Synonyms: 1-(p-tolylsulfonyl)triazole
• CAS NO: 1219601-57-6
• Molecular Weight: 223.255
• Mol File: 1219601-57-6.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: 1-(p-tolylsulfonyl)triazole(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(p-tolylsulfonyl)triazole(1219601-57-6)
• EPA Substance Registry System: 1-(p-tolylsulfonyl)triazole(1219601-57-6)

Safety Data

• Hazardous Substances Data: 1219601-57-6(Hazardous Substances Data)

Usage

Type of compound

Sulfonyl triazole

Usage

Reagent in organic synthesis and medicinal chemistry

Potential as an inhibitor

Protein tyrosine phosphatases and phosphodiesterases

Applications

Studying enzymes, developing new therapeutic agents

Upstream product

• 288-36-8 1,2,3-triazole 
• 98-59-9 p-toluenesulfonyl chloride 
• 288-88-0 1,2,4-Triazole 

Downstream Products

• 118078-97-0 1-(2-pyridyl)1,2,3-triazole 
• 153653-01-1 2-(1,2,3-triazol-2-yl)pyridine 
• 1219601-40-7 C₆H₅N₅ 
• 1219601-39-4 C₆H₅N₅ 
• 30597-96-7 2-[1,2,3]triazol-1-yl-pyrimidine 
• 1219601-12-3 C₁₃H₁₀N₄ 
• 1219601-13-4 C₁₃H₁₀N₄ 
• 1312297-98-5 C₁₉H₁₉NO₃S 
• 108717-96-0 1-benzyl-4-phenyl-1H-[1,2,3]triazole 
• 1339958-80-3 2-benzyl-4-phenyl-2H-1,2,3-triazole 
• 14316-14-4 N-(2-hydroxy-ethyl)-4-methyl-benzenesulfonamide 
• 57483-27-9 N-(2-oxoethyl)-4-methylbenzenesulfonamide 

Relevant articles and documents

SUBSTITUTED ARYLMETHYLUREAS AND HETEROARYLMETHYLUREAS, ANALOGUES THEREOF, AND METHODS USING SAME

The present invention includes substituted arylmethyl ureas and heteroarylmethyl-ureas, and compositions comprising the same, that can be used to treat or prevent hepatitis B virus (HBV) infections in a patient.

Rh-catalyzed transannulation of N-tosyl-1,2,3-triazoles with terminal alkynes

The first transannulation of 1,2,3-triazoles with terminal alkynes into pyrroles is reported. The reaction proceeds in the presence of a Rh 2(oct)4/AgOCOCF3 binary catalyst system providing a straightforward approach to 1,2,4-trisubstituted pyrroles in good to excellent yields.

Pharmaceutical use of N-carbamoylazole derivatives

The present invention relates to use of 1-carbamoylazole derivatives as medicaments and pharmaceutical compositions containing 1-carbamoylazole derivatives as the active ingredient, based on their DPPIV inhibiting effects. The present invention provides a